Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lonafarnib + Gemcitabine in Advanced Urothelial Cancer
NCT00006351Phase 2Completed
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Jun 2000
- Primary completion
- Dec 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of lonafarnib in urothelial carcinoma (UC), sponsored by European Organisation for Research and Treatment of Cancer. Started Jun 2000; status: completed.
02
Drugs
lonafarnib
03
Conditions
urothelial carcinoma (UC)
Beyond the preview
Go deeper on NCT00006351.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006351.